Tuberculosis
Tuberculosis (TB) remains one of the top 10 causes of death worldwide. TB is a preventable and curable disease, yet 10.4 million contracted TB and 1.7 million died in 2016 according to the WHO. Our experts review the research that is making a positive impact in the fight against TB. 53 million lives were saved between 2000 and 2016 with diagnosis and treatment. Can we #EndTB in the next 12 years? All articles in this collection are FREE to read until May 1 2018 - and anytime with an Annual Reviews subscription. Articles in the Annual Review of Public Health are Open Access.
Collection details
Nonprofit publisher Annual Reviews, invites expert authors who work at the forefront of fighting TB (which stubbornly remains one of the top 10 causes of death worldwide) to synthesize research that can help make a positive impact to eradicating this preventable and curable disease. In support of World TB Day (March 24th each year), we recognize some of the authors that have contributed to Annual Reviews’ journals. These articles are freely available through May 1 2018 and are always available to subscribers.
Editors
Collection Information
| ScienceOpen disciplines: | Medicine, Infectious disease & Microbiology |
| Keywords: | Infectious Disease, Tuberculosis, TB, Drug resistant, Immune response, Genetics, Drug development, Epidemic, TB Drug Target, Pathogen |
| DOI: | 10.14293/S2199-1006.1.SOR-MED.CL6YXBM.v1 |